← All organizations

Epimmune

For profit

Also known as: Pharmexa-Epimmune

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Apr 1, 2007

Acquired by IDM Pharma → Takeda on Mar 17, 2005

Timeline

1990s

Jun 1, 1997
Epimmune— Founded

2000s

Mar 17, 2005
IDM Pharma— Acquired By
May 18, 2009
Takeda— Now

Drugs by trial phase (5 distinct, 5 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT00428337CollaboratorPhase 1Apr 1, 2007
NCT00532974Lead sponsorPhase 1Oct 1, 2006
NCT00532974CollaboratorPhase 1Oct 1, 2006
NCT00104780Study chairPhase 2Dec 1, 2004
NCT00104780Lead sponsorPhase 2Dec 1, 2004
NCT00054912Lead sponsorPhase 1Feb 1, 2003
NCT00054899Lead sponsorPhase 1Jan 1, 2003

Details

Founded: San Diego, CA, US Jun 1, 1997
Last known activity: Apr 1, 2007